Dr. Amit Kumar, CEO of Anixa Biosciences, Inc. will participate in a panel presentation discussing the latest science in immunotherapy at a two day symposium titled, “Frontiers in Cancer Immunotherapy,” hosted by the New York Academy of Sciences on May 14–15, 2019.
March 27, 2019
· 3 min read